Treatment of bilateral Irvine-Gass syndrome with suprachoroidal triamcinolone injection
Document Type
Article
Department
Ophthalmology
Abstract
A woman in her 60s underwent uneventful sequential cataract surgeries for both eyes and achieved 6/6 visual acuity postoperatively. 7 weeks after surgery, she developed bilateral cystoid macular oedema (CME) and her vision declined to a best-corrected visual acuity (BCVA) of 6/21 in the right eye and 6/24 in the left eye. She was diagnosed with bilateral Irvine-Gass syndrome (IGS). Initial treatment with topical steroids and non-steroidal anti-inflammatory drugs was ineffective. She was subsequently treated with a single dose of suprachoroidal triamcinolone acetonide (SCTA) injections (40 mg/mL) in each eye. This intervention led to a rapid and complete resolution of CME within 2 weeks. Her BCVA recovered to 6/6 in both eyes and remained stable for 8 months post-SCTA injections.This case highlights that SCTA may represent a promising treatment option for IGS, offering successful anatomical and functional outcomes in patients who do not respond to conventional topical therapy.
Publication (Name of Journal)
BMJ Case Reports
DOI
10.1136/bcr-2025-269913
Recommended Citation
Zahra, F.,
Abid, K.,
Rashid, S.,
Anis, M.,
Tayyab, H.
(2026). Treatment of bilateral Irvine-Gass syndrome with suprachoroidal triamcinolone injection. BMJ Case Reports, 19(9).
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_ophthalmol/206
Comments
Pagination is not provided by author/publisher.